Aprea Therapeutics, Inc. Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aprea Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aprea Therapeutics, Inc. for May 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 10,200 | 358,530 | 90,572 | 100.8 K to 90.6 K (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 244,800 | 8,604,720 | 2,173,748 | 2.4 M to 2.2 M (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 35.15 | 10,200 | 358,530 | 90,572 | 100.8 K to 90.6 K (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 35.15 | 244,800 | 8,604,720 | 2,173,748 | 2.4 M to 2.2 M (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 10,200 | 358,530 | 90,572 | 100.8 K to 90.6 K (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 244,800 | 8,604,720 | 2,173,748 | 2.4 M to 2.2 M (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 35.15 | 10,200 | 358,530 | 90,572 | 100.8 K to 90.6 K (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 35.15 | 244,800 | 8,604,720 | 2,173,748 | 2.4 M to 2.2 M (-10.12 %) |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | 10% Owner | Sell | J | 0.00 | 1,178 | 0 | 0 | 1.2 K to 0 (-100.00 %) |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | 10% Owner | Buy | J | 0.00 | 1,178 | 0 | 1,178 | 0 to 1.2 K |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | 10% Owner | Sell | J | 0.00 | 16,428 | 0 | 0 | 16.4 K to 0 (-100.00 %) |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | 10% Owner | Buy | J | 0.00 | 16,428 | 0 | 16,428 | 0 to 16.4 K |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | 10% Owner | Sell | J | 0.00 | 58,889 | 0 | 109,374 | 168.3 K to 109.4 K (-35.00 %) |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | 10% Owner | Sell | J | 0.00 | 25,794 | 0 | 47,823 | 73.6 K to 47.8 K (-35.04 %) |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | 10% Owner | Sell | J | 0.00 | 23,275 | 0 | 43,231 | 66.5 K to 43.2 K (-35.00 %) |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | 10% Owner | Sell | J | 0.00 | 773,805 | 0 | 1,437,132 | 2.2 M to 1.4 M (-35.00 %) |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | 10% Owner | Buy | J | 0.00 | 168,263 | 0 | 168,263 | 0 to 168.3 K |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | 10% Owner | Buy | J | 0.00 | 73,617 | 0 | 73,617 | 0 to 73.6 K |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | 10% Owner | Buy | J | 0.00 | 66,506 | 0 | 66,506 | 0 to 66.5 K |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | 10% Owner | Buy | J | 0.00 | 2,210,937 | 0 | 2,210,937 | 0 to 2.2 M |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | 10% Owner | Sell | J | 0.00 | 2,519,323 | 0 | 0 | 2.5 M to 0 (-100.00 %) |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 1,734 | 0 | 0 | 1.7 K to 0 (-100.00 %) |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 1,734 | 0 | 1,734 | 0 to 1.7 K |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 1,750 | 0 | 0 | 1.8 K to 0 (-100.00 %) |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 1,750 | 0 | 1,750 | 0 to 1.8 K |
May 20 2020 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 116,664 | 0 | 216,669 | 333.3 K to 216.7 K (-35.00 %) |